Article
What the FTC announced
On March 20, FTC Chairman Andrew Ferguson directed staff to form a Healthcare Task Force drawing on the Bureaus of Competition, Consumer Protection and Economics, the Office of Policy Planning and the Office of Technology. The group is charged with leading targeted enforcement and advocacy, building agencywide investigation strategies, finding cases where the FTC can weigh in through amicus briefs or statements of interest, and identifying emerging problems. The agency said it expects to bring in partners such as HHS and the Justice Department.
The announcement tied the effort to the administration’s push for a more competitive and affordable health system and pointed to recent actions: a February settlement with Express Scripts that the FTC said could cut patients’ out-of-pocket drug costs by up to $7 billion over 10 years, a successful challenge to Edwards’ planned purchase of JenaValve, and the abandoned Alcon-Lensar deal. Ferguson’s memo also noted that many patients still face high costs and limited access.
Why hospitals should pay attention
The release does not single out hospitals, and none of the cited cases involve a health system. Still, health care is roughly 18% of the U.S. economy, and a standing team that combines merger reviewers, consumer protection lawyers and economists makes it easier for the agency to connect issues that used to be handled separately. A hospital transaction, a physician employment practice and a patient billing complaint could now land in front of the same group.
Coordination with HHS and the Justice Department also matters. Information that surfaces in one agency’s review can prompt questions from another, and amicus filings let the FTC shape private lawsuits and state cases without bringing its own action.
Practical steps for leadership teams
- Transactions: Build more time and documentation into merger, affiliation and physician group deals. Prepare a clear account of patient benefits, pricing commitments and access improvements before regulators ask.
- Internal documents: Remind executives and board members that strategy decks and emails about market share or payer leverage can become evidence.
- Workforce terms: Review physician and staff agreements for restrictive provisions that could draw consumer protection or competition questions.
- Patient-facing practices: Check that marketing, price estimates and billing communications are accurate and consistent, since consumer protection staff now sit on the same team.
Boards with pending or planned deals should ask counsel how the task force might affect timing and conditions.
Archive entry for Mar 22, 2026, added Nov. 11, 2026.